Tag : investigational immunotherapy

Clinical Research, Pharma & Healthcare Financing

BeOne Medicines Reveals Breakthrough CLL & MCL Data at EHA 2025

Business Wire
by Business Wire0177
Clinical results from next-generation investigational therapies demonstrate potential for deep, durable responses that support the advancement of pivotal studies and future regulatory filings Phase 1...
Workforce Development & Leadership

TriSalus Announces New CMS Code for TriNav® Mapping System

Business Wire
by Business Wire0249
TriSalus Life Sciences®, Inc. (“TriSalus” or the “Company”) (Nasdaq: TLSI), which seeks to transform outcomes for patients with solid tumors by integrating our innovative delivery...